Active ingredient
Fosphenytoin
16 finished FDA listings contain Fosphenytoin as their only active ingredient.
FDA NDC Directory
- Ingredient names as written by FDA
- FOSPHENYTOIN SODIUM
- Dosage forms
- Injection, Injection, Solution
- Routes
- Intramuscular, Intravenous
- Manufacturers / labelers
- 8
- Strengths listed
- 50 mg/ml
- Brand names in FDA listings
- Cerebyx, Fosphenytoin
RxNorm (National Library of Medicine)
Ingredient concept RxCUI 72236
Drugs@FDA applications
Linked only where the FDA listing’s application number matches Drugs@FDA exactly. A listing in the NDC Directory does not by itself mean FDA approval.
| Application | Sponsor | Original approval | Listings |
|---|---|---|---|
| NDA 020450 | PARKE DAVIS | 1996-08-05 | 3 |
| ANDA 077989 | HIKMA | 2007-08-06 | 2 |
| ANDA 078052 | FRESENIUS KABI USA | 2007-08-06 | 1 |
| ANDA 078476 | AMNEAL | 2008-03-18 | 2 |
| ANDA 078765 | HIKMA FARMACEUTICA | 2009-12-02 | 2 |
| ANDA 214926 | GLAND | 2023-10-13 | 6 |
Official labeling on DailyMed
- FOSPHENYTOIN SODIUM INJECTION, SOLUTION [GLENMARK PHARMACEUTICALS INC., USA] · version 3 · 2026-03-23
- FOSPHENYTOIN SODIUM INJECTION, SOLUTION [GLENMARK PHARMACEUTICALS INC., USA] · version 3 · 2026-03-09
- CEREBYX (FOSPHENYTOIN SODIUM) INJECTION, SOLUTION [PFIZER LABORATORIES DIV PFIZER INC] · version 38 · 2025-08-29
- CEREBYX (FOSPHENYTOIN SODIUM) INJECTION, SOLUTION [PFIZER LABORATORIES DIV PFIZER INC] · version 29 · 2025-05-21
- FOSPHENYTOIN SODIUM INJECTION, SOLUTION [SAGENT PHARMACEUTICALS] · version 1 · 2025-01-15
- FOSPHENYTOIN SODIUM INJECTION [AMNEAL PHARMACEUTICALS LLC] · version 16 · 2024-10-28
- FOSPHENYTOIN SODIUM INJECTION [HIKMA PHARMACEUTICALS USA INC.] · version 22 · 2024-04-11
- FOSPHENYTOIN SODIUM INJECTION, SOLUTION [GLAND PHARMA LIMITED] · version 6 · 2023-10-24
- FOSPHENYTOIN (FOSPHENYTOIN SODIUM) INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] · version 14 · 2023-05-19
- FOSPHENYTOIN SODIUM INJECTION, SOLUTION [WEST-WARD PHARMACEUTICALS CORP] · version 10 · 2018-01-08
Sources: FDA NDC Directory (2026-09-29), RxNorm, Drugs@FDA, DailyMed. Each source’s facts are shown separately as published.